1. |
Gasser A, Ho T, Cheng X, et al. An ankyrinG-binding motif is necessary and sufficient for targeting Nav1. 6 sodium channels to axon initial segments and nodes of Ranvier. The Journal of neuroscience:the official journal of the Society for Neuroscience, 2012, 32(21): 7232-7243.
|
2. |
Veeramah K, O'brien J, Meisler M, et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. American journal of human genetics, 2012, 90(3): 502-510.
|
3. |
Gardella E, Becker F, Møller R, et al. Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation. Annals of neurology, 2016, 79(3): 428-436.
|
4. |
Johannesen K, Gardella E, Encinas A, et al. The spectrum of intermediate SCN8A-related epilepsy. Epilepsia, 2019, 60(5): 830-844.
|
5. |
Larsen J, Carvill G, Gardella E, et al. The phenotypic spectrum of SCN8A encephalopathy. Neurology, 2015, 84(5): 480-489.
|
6. |
Wagnon J, Barker B, Ottolini M, et al. SCN8ALoss-of-function variants of in intellectual disability without seizures. Neurology. Genetics, 2017, 3(4): e170.
|
7. |
Butler K, Da Silva C, Shafir Y, et al. De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis. Epilepsy research, 2017, 129: 17-25.
|
8. |
Wagnon J, Mencacci N, Barker B, et al. Partial loss-of-function of sodium channel SCN8A in familial isolated myoclonus. Human mutation, 2018, 39(7): 965-969.
|
9. |
Johannesen K, Gardella E, Scheffer I, et al. Early mortality in SCN8A-related epilepsies. Epilepsy research, 2018, 143: 79-81.
|
10. |
Gardella E, Marini C, Trivisano M, et al. SCN8AThe phenotype of developmental and epileptic encephalopathy. Neurology, 2018, 91(12): e1112-e1124.
|
11. |
Kruger L, Isom L. Voltage-gated Na+ channels: not just for conduction. Cold Spring Harbor perspectives in biology, 2016, 8(6): a029264.
|
12. |
Brunklaus A, Lal D. Sodium channel epilepsies and neurodevelopmental disorders: from disease mechanisms to clinical application. Developmental medicine and child neurology, 2020, 62(7): 784-792.
|
13. |
Meisler M, Helman G, Hammer M, et al. SCN8A encephalopathy: Research progress and prospects. Epilepsia, 2016, 57(7): 1027-1035.
|
14. |
Ademuwagun I, Rotimi S, Syrbe S, et al. Voltage gated sodium channel genes in epilepsy: mutations, functional studies, and treatment dimensions. Frontiers in neurology, 2021, 12: 600050.
|
15. |
Blanchard M, Willemsen M, Walker J, et al. De novo gain- of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy. Journal of medical genetics, 2015, 52(5): 330-337.
|
16. |
Gardella E, Møller R. Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes. Epilepsia, 2019: S77-S85.
|
17. |
Liu Y, Schubert J, Sonnenberg L, et al. Neuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability. Brain:a journal of neurology, 2019, 142(2): 376-390.
|
18. |
Johannesen K, Liu Y, Koko M, et al. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications. Brain : a journal of neurology, 2021.
|
19. |
Ogiwara I, Miyamoto H, Morita N, et al. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007, 27(22): 5903-5914.
|
20. |
Wagnon J, Meisler M. Recurrent and Non-Recurrent Mutations of SCN8A in Epileptic Encephalopathy. Frontiers in neurology, 2015, 6: 104.
|
21. |
Tidball A, Lopez-Santiago L, Yuan Y, et al. Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons. Brain:a journal of neurology, 2020, 143(10): 3025-3040.
|
22. |
Luo H, Xie L, Hong S, et al. The genotype and phenotype of proline-rich transmembrane protein 2 associated disorders in Chinese children. Frontiers in pediatrics, 2021, 9: 676616.
|
23. |
Anand G, Collett-White F, Orsini A, et al. Autosomal dominant SCN8A mutation with an unusually mild phenotype. European journal of paediatric neurology:EJPN:official journal of the European Paediatric Neurology Society, 2016, 20(5): 761-765.
|
24. |
Wang J, Gao H, Bao X, et al. SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures. BMC medical genetics, 2017, 18(1): 104.
|
25. |
Parrini E, Marini C, Mei D, et al. Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes. Human mutation, 2017, 38(2): 216-225.
|
26. |
Bagnasco I, Dassi P, Blé R, et al. A relatively mild phenotype associated with mutation of SCN8A. Seizure, 2018, 56: 47-49.
|
27. |
Wagnon J, Barker B, Hounshell J, et al. Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy. Annals of clinical and translational neurology, 2016, 3(2): 114-123.
|
28. |
Denis J, Villeneuve N, Cacciagli P, et al. Clinical study of 19 patients with SCN8A-related epilepsy: Two modes of onset regarding EEG and seizures. Epilepsia, 2019, 60(5): 845-856.
|
29. |
Mcnally M, Johnson J, Huisman T, et al. SCN8A epileptic encephalopathy: detection of fetal seizures guides multidisciplinary approach to diagnosis and treatment. Pediatric neurology, 2016, 64: 87-91.
|
30. |
Trivisano M, Pavia G, Ferretti A, et al. Generalized tonic seizures with autonomic signs are the hallmark of SCN8A developmental and epileptic encephalopathy. Epilepsy & behavior:E& B, 2019, 96: 219-223.
|
31. |
De Kovel C, Meisler M, Brilstra E, et al. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy. Epilepsy research, 2014, 108(9): 1511-1518.
|
32. |
Ohba C, Kato M, Takahashi S, et al. Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia, 2014, 55(7): 994-1000.
|
33. |
姚春美, 赵荣江, 邓亚仙, 等. SCN8A基因突变相关癫痫性脑病2例报告并文献复习. 临床儿科杂志, 2019, 37(6): 462-465.
|
34. |
Schreiber J, Tochen L, Brown M, et al. A multi-disciplinary clinic for SCN8A-related epilepsy. Epilepsy research, 2020, 159: 106261.
|
35. |
Nickels K, Grossardt B, Wirrell E. Epilepsy-related mortality is low in children: a 30-year population-based study in Olmsted County, MN. Epilepsia, 2012, 53(12): 2164-2171.
|
36. |
Keller A, Whitney R, Li S, et al. Incidence of sudden unexpected death in epilepsy in children is similar to adults. Neurology, 2018, 91(2): e107-e111.
|
37. |
Abdel-Mannan O, Taylor H, Donner E, et al. A systematic review of sudden unexpected death in epilepsy (SUDEP) in childhood. Epilepsy & behavior:E& B, 2019, 90: 99-106.
|
38. |
Frasier C, Wagnon J, Bao Y, et al. SCN8ACardiac arrhythmia in a mouse model of sodium channel epileptic encephalopathy. Proceedings of the National Academy of Sciences of the United States of America, 2016, 113(45): 12838-12843.
|
39. |
Trudeau M, Dalton J, Day J, et al. Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation. Journal of medical genetics, 2006, 43(6): 527-530.
|
40. |
Canafoglia L, Franceschetti S, Granata T, et al. SCN8A splicing mutation causing skipping of the exon 15 associated with intellectual disability and cortical myoclonus. Seizure, 2020, 82: 56-58.
|
41. |
Boerma R, Braun K, Van Den Broek M, et al. Remarkable phenytoin sensitivity in 4 children with SCN8A-related epilepsy: a molecular neuropharmacological approach. Neurotherapeutics, 2016, 13(1): 192-197.
|
42. |
Møller R, Johannesen K. Precision medicine: SCN8A encephalopathy treated with sodium channel blockers. Neurotherapeutics, 2016, 13(1): 190-191.
|
43. |
Atkin T, Maher C, Gerlach A, et al. A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsy. Epilepsia, 2018, 59(4): 802-813.
|
44. |
Lenk G, Jafar-Nejad P, Hill S, et al. Scn8a antisense oligonucleotide is protective in mouse models of SCN8A encephalopathy and dravet syndrome. Annals of neurology, 2020, 87(3): 339-346.
|